WKL Stock Analysis: Wolters Kluwer | AS
Specialty Business Services | AS, Netherlands | Market Cap: 15.768m EUR | 12M Return: -35.4% | NL0000395903 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 77.1M
EPS Trend: -22.9%
Rev. Trend: 94.3%
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Wolters Kluwer N.V. (WKL) is a Netherlands-headquartered information services company founded in 1836, based in Alphen aan den Rijn. It provides professional information, software, and services through five operating segments: Health; Tax & Accounting; Financial & Corporate Compliance; Legal & Regulatory; and Corporate Performance & ESG. Its products target specialized professional end markets, including hospitals and clinicians, tax and accounting firms, financial institutions, law firms, corporate legal departments, and government entities, with operations spanning Europe, North America, and Asia Pacific.
The company operates as a B2B professional information and software provider, selling subscription-based content, compliance tools, and workflow software to expert users in regulated industries. It is classified in the GICS Industrials sector under Diversified Support Services, reflecting its mix of data, analytics, and software products rather than a pure media or pure software profile.
- GenAI-powered Health solutions accelerate recurring subscription revenue growth
- Regulatory complexity drives demand across Tax and Compliance software segments
- Share buybacks offset EUR strength and subscription margin pressure
| Net Income: 1.33b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA -3.69 > 1.0 |
| NWC/Revenue: -23.52% < 20% (prev -17.39%; Δ -6.12% < -1%) |
| CFO/TA 0.17 > 3% & CFO 1.69b > Net Income 1.33b |
| Net Debt (4.25b) to EBITDA (2.02b): 2.10 < 3 |
| Current Ratio: 0.69 > 1.5 & < 3 |
| Outstanding Shares: last quarter (225.3m) vs 12m ago -8.41% < -2% |
| Gross Margin: 74.07% > 18% (prev 64.77%; Δ 9.31% > 0.5%) |
| Asset Turnover: 61.11% > 50% (prev 62.44%; Δ -1.34% > 0%) |
| Interest Coverage Ratio: 14.34 > 6 (EBIT TTM 1.56b / Interest Expense TTM 109.0m) |
| A: -0.14 (Total Current Assets 3.17b - Total Current Liabilities 4.61b) / Total Assets 10.3b |
| B: 0.11 (Retained Earnings 1.17b / Total Assets 10.3b) |
| C: 0.16 (EBIT TTM 1.56b / Avg Total Assets 9.99b) |
| D: 0.10 (Book Value of Equity 940.0m / Total Liabilities 9.31b) |
| Altman-Z'' = 0.61 = B |
| DSRI: 1.00 (Receivables 1.61b/1.60b, Revenue 6.11b/6.08b) |
| GMI: 0.87 (GM 64.77% / 74.07%) |
| AQI: 0.94 (AQ_t 0.67 / AQ_t-1 0.71) |
| SGI: 1.00 (Revenue 6.11b / 6.08b) |
| TATA: -0.03 (NI 1.33b - CFO 1.69b) / TA 10.3b) |
| Beneish M = -3.17 (Cap -4..+1) = AA |
As of August 28, 2026, the stock is trading at EUR 70.12 with a total of 925,049 shares traded. Over the past week, the price has changed by -0.93%, over one month by +4.10%, over three months by +14.73% and over the past year by -35.38%.
Current recommended Stop Loss: 64.40 (which is 8.2% or 2.2 ATR below the current price).
Wolters Kluwer has no consensus analysts rating.
P/E Trailing = 12.0991
P/E Forward = 12.3609
P/S = 2.5823
P/B = 16.7363
P/EG = 1.9948
Revenue TTM = 6.11b EUR
EBIT TTM = 1.56b EUR
EBITDA TTM = 2.02b EUR
Long Term Debt = 3.95b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 1.33b EUR (from shortTermDebt, last quarter)
Debt = 5.74b EUR (from shortLongTermDebtTotal, last quarter) + Leases 217.0m
Net Debt = 4.25b EUR (calculated: Debt 5.74b - CCE 1.49b)
Enterprise Value = 20.0b EUR (15.8b + Debt 5.74b - CCE 1.49b)
Interest Coverage Ratio = 14.34 (Ebit TTM 1.56b / Interest Expense TTM 109.0m)
EV/FCF = 14.36x (Enterprise Value 20.0b / FCF TTM 1.39b)
FCF Yield = 6.96% (FCF TTM 1.39b / Enterprise Value 20.0b)
FCF Margin = 22.83% (FCF TTM 1.39b / Revenue TTM 6.11b)
Net Margin = 21.86% (Net Income TTM 1.33b / Revenue TTM 6.11b)
Gross Margin = 74.07% ((Revenue TTM 6.11b - Cost of Revenue TTM 1.58b) / Revenue TTM)
Gross Margin QoQ = 74.41% (prev 73.74%)
Tobins Q-Ratio = 1.95 (Enterprise Value 20.0b / Total Assets 10.3b)
Interest Expense / Debt = 1.90% (Interest Expense 109.0m / Debt 5.74b)
Taxrate = 20.63% (347.0m / 1.68b)
NOPAT = 1.24b (EBIT 1.56b * (1 - 20.63%))
Current Ratio = 0.69 (Total Current Assets 3.17b / Total Current Liabilities 4.61b)
Debt / Equity = 6.11 (Debt 5.74b / totalStockholderEquity, last quarter 940.0m)
Debt / EBITDA = 2.10 (Net Debt 4.25b / EBITDA 2.02b)
Debt / FCF = 3.05 (Net Debt 4.25b / FCF TTM 1.39b)
Total Stockholder Equity = 1.04b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.36% (Net Income 1.33b / Total Assets 10.3b)
RoE = 128.1% (Net Income TTM 1.33b / Total Stockholder Equity 1.04b)
RoCE = 31.33% (EBIT 1.56b / Capital Employed (Equity 1.04b + L.T.Debt 3.95b))
RoIC = 18.59% (NOPAT 1.24b / Invested Capital 6.67b)
WACC = 4.32% (E(15.8b)/V(21.5b) * Re(5.35%) + D(5.74b)/V(21.5b) * Rd(1.90%) * (1-Tc(0.21)))
Discount Rate = 5.35% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -99.04 | Cagr: -6.32%
[DCF] Terminal Value 73.10% ; FCFF base≈1.51b ; Y1≈1.32b ; Y5≈1.07b
[DCF] Fair Price = 57.98 (EV 17.2b - Net Debt 4.25b = Equity 12.9b / Shares 222.8m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -22.92 | EPS CAGR: -2.90% | SUE: N/A | # QB: 0
Revenue Correlation: 94.32 | Revenue CAGR: 3.86% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=5.66 | Chg30d=+0.35% | Revisions=+58% | GrowthEPS=+6.9% | GrowthRev=+2.5%
EPS next Year (2027-12-31): EPS=6.26 | Chg30d=+0.32% | Revisions=+62% | GrowthEPS=+10.6% | GrowthRev=+5.9%
[Analyst] Revisions Ratio: +68% (up=17, down=2)